Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to
provide, or continue to
provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to
more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the
zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
It's a good source of the B vitamin riboflavin (61 percent Daily Value), as well as several minerals: a standard 1/4 - cup serving
provides more than 100 percent of the Daily Value for manganese, and roughly 8 percent of the Daily Value for both calcium and
zinc.
They contain
more bioavailable sources of iron than rice cereal and
provide other important nutrients such as
zinc, B6, and B12.
Around six months of age, most breastfeeding babies» iron and
zinc stores start to diminish and they need
more than what can be
provided through breast milk alone.
It also
provides more than 100 % of the needed levels of Vitamin A, Calcium,
Zinc and Iron, to prevent nutritional inadequacies.
It should be noted though that after the first six months, babies will need to have
more zinc and iron that can not always be
provided by milk alone.
Instead, these two unprocessed grains
provide complex carbohydrates filled with fiber, vitamin B2,
zinc, magnesium, and
more.
Eat
more fruits and vegetables instead, to
provide antioxidant vitamins C and E. Snack on pumpkins seeds, and increase your meat intake to insure you are getting adequates amounts of
zinc.
Oysters contain
more zinc per serving than any other food, but red meat and poultry
provide the majority of
zinc in the American diet.
In addition to being a great source of high - quality protein, shrimp and prawns
provide several B vitamins, copper, and
zinc, and
more than half of the RDI for selenium.
If you are not deficient in
zinc, then you should still consider getting
more of it; this will
provide you with extra acne benefits such as accelerated wound healing.
Of the chemical sunscreen ingredients, avobenzone is the «best» but I personally try to opt for physical sunscreens that contain
zinc oxide or titanium dioxide, since they're
more stable and
provide longer UV protection.
You can also look at the guaranteed analysis
provided by Purina to see that they add
more than the minimum amounts of linoleic acid and
zinc.